Ar­mored CAR-Ts? Memo­r­i­al Sloan Ket­ter­ing en­gi­neers CAR-T loaded with check­point in­hibitors

Sci­en­tists at Memo­r­i­al Sloan Ket­ter­ing have en­gi­neered a hy­brid can­cer ther­a­py that might just bring two of hottest ar­eas of on­col­o­gy sci­ence to­geth­er in one pack­age: CAR-T and check­point in­hibitors.

That’s the hope of a team of MSK re­searchers work­ing in the labs of Re­nier Bren­t­jens, a renowned physi­cian-sci­en­tist in New York City. They just pub­lished a pa­per in Na­ture — au­thored by Sar­wish Rafiq, Oladapo Yeku, and Hol­lie Jack­sonout­lin­ing their suc­cess in an­i­mal mod­els.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.